Vivo Opportunity funds disclose 24% stake in InMed Pharmaceuticals
Vivo Opportunity Fund Holdings, L.P. and affiliated entities disclosed ownership of 790,979 common shares of InMed Pharmaceuticals, representing 24% of the…
24%790,979May 19
Company
SEC filing news and material events for InMed Pharmaceuticals Inc., briefed from primary-source filings.
1 story
Vivo Opportunity Fund Holdings, L.P. and affiliated entities disclosed ownership of 790,979 common shares of InMed Pharmaceuticals, representing 24% of the…